IMS 2026 – The impact of side effects from generic forms of lenalidomide
Published:
What happens when patients report debilitating side effects after switching to generic lenalidomide? In this article, we explore what Myeloma UK heard from people living with myeloma and the questions this raises for side effect management in clinical practice.
Sign up and become a member of the Myeloma UK HCP Hub
Access exclusive content like this and join in the conversation.
Already have an account?